Skip to content

US · AHG · SOFTWARE - SERVICES

Akso Health Group (AHG) intrinsic value and stock valuation

$1.26as of 2026-11-21 · Mkt cap 1.15B

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Akso Health Group DCF and intrinsic value

InvestorsCraft values AHG with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from AHG’s statements →

Akso Health Group Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Technology · Software - Services Qingdao, SD Qingdao ahgtop.com

How the business is doing

Fiscal 2015–2026, USD

Revenue
$13.8M+51.2% 5y CAGRd
20152026
Net income
-$-18.67M
20152026
Free cash flow
-$-188.46M
20152026
Total equity
$180.9M+60% 5y CAGRd
20152026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2015–2026, USD
20262025202420232022
Revenue$13.8M$14.8M$2.41M$13.2M$6M
Operating income-$-4M-$-166.3M-$-8.64M-$-14.27M-$-3.26M
Net income-$-18.67M-$-134.98M-$-9.46M-$-1.36M-$-16.85M
EPSd-$-25.83K-$-473.45K-$-396.98K-$-178.48K-$-2.55M
Operating cash flow-$-12.79M$1.18M$1.35M-$-3.25M-$-8.63M
Capital expenditure-$-175.67M-$-150K$0.00$0.00-$0.00
Free cash flow-$-188.46M$1.02M$1.35M-$-3.25M-$-8.63M
Total assets$189.6M$215M$142M$20.5M$62.8M
Total debt$380K$80K$0.00$0.00$0.00
Net debt$210K-$-176.15M-$-85.17M-$-7.92M-$-18.43M
Total equity$180.9M$199.2M$138.4M$8.84M$12.3M
Cash and short-term investments$170K$176.2M$85.2M$7.92M$18.4M
Income statement
20262025202420232022
Revenue$13.8M$14.8M$2.41M$13.2M$6M
Cost of revenue$13.8M$15.1M$2.29M$11.9M$5.39M
Gross profit-$-10K-$-280K$120K$1.27M$610K
Research and development expenses$0.00$0.00$0.00$0.00$420K
Selling, general and administrative expenses$3.99M$3.64M$8.76M$15.5M$3.06M
Other expenses$0.00$162.4M$0.00$0.00$380K
Operating expenses$3.99M$166M$8.76M$15.5M$3.87M
Cost and expenses$17.8M$181.1M$11.1M$27.5M$9.26M
Interest income$0.00$0.00$0.00$0.00$0.00
Interest expense$0.00$0.00$0.00$0.00$800K
Depreciation and amortization$2.37M$2.15M$0.00$20K$20K
Ebitda-$-1.63M-$-1.77M-$-8.64M-$-14.27M-$-3.19M
Operating income-$-4M-$-166.3M-$-8.64M-$-14.27M-$-3.26M
Total other income/expenses, net-$-16.7M$30K-$-450K$1.2M-$-750K
Income before tax-$-20.7M-$-166.27M-$-9.09M-$-13.07M-$-4.01M
Income tax expense-$-1.99M-$-30.8M$20K$20K$90K
Net income-$-18.67M-$-134.98M-$-9.46M-$-1.36M-$-16.85M
Weighted average shares outstanding$722.7M$285.1M$20.8M$7.62M$6.62M
Weighted average diluted shares outstanding$722.7M$285.1M$23.8M$7.62M$6.62M
Balance sheet
20262025202420232022
Cash and short-term investments$170K$176.2M$85.2M$7.92M$18.4M
Net receivables$1.28M$12.9M$0.00$9.23M$20M
Inventory$200K$190K$190K$1.69M$7.8M
Total current assets$189.6M$196.1M$142M$20.5M$62.6M
Property, plant and equipment, net$30K$110K$0.00$0.00$60K
Goodwill and intangible assets$60K$18.7M$0.00$0.00$0.00
Long-term investments$0.00$0.00$0.00$0.00$0.00
Total non-current assets$90K$18.8M$0.00$0.00$180K
Total assets$189.6M$215M$142M$20.5M$62.8M
Accounts payable$0.00$0.00$0.00$0.00$0.00
Short-term debt$370K$40K$0.00$0.00$0.00
Deferred revenue$4.41M$10.2M$420K$190K$0.00
Total current liabilities$8.71M$13.8M$3.59M$11.6M$50.5M
Long-term debt$0.00$40K$0.00$0.00$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$0.00$1.99M$0.00$0.00$0.00
Capital lease obligations$30K$80K$0.00$0.00$0.00
Total liabilities$8.71M$15.8M$3.59M$11.6M$50.5M
Common stock$260K$170K$40K$10K$10K
Retained earnings-$-217.58M-$-198.9M-$-63.93M-$-54.47M-$-53.11M
Accumulated other comprehensive income (loss)-$-3.28M-$-3.77M-$-4.09M-$-3.85M-$-1.65M
Total equity$180.9M$199.2M$138.4M$8.84M$12.3M
Total investments$0.00$0.00$0.00$0.00$0.00
Total debt$380K$80K$0.00$0.00$0.00
Net debt$210K-$-176.15M-$-85.17M-$-7.92M-$-18.43M
Cash flow statement
20262025202420232022
Net income-$-18.72M-$-135.47M-$-9.12M-$-13.08M-$-16.85M
Depreciation and amortization$2.37M$2.15M$0.00$0.00$20K
Stock-based compensation$0.00$0.00$0.00$0.00$390K
Change in working capital-$-11.35M$3.02M$2.06M-$-1.17M-$-2.56M
Accounts receivable-$-440K-$-860K$330K-$-8.1M$10K
Inventory$0.00$0.00$1.5M$6.11M-$-7.8M
Accounts payable$310K$420K$170K$710K-$-100K
Net cash provided by operating activities-$-12.79M$1.18M$1.35M-$-3.25M-$-8.63M
Investments in property, plant and equipment-$0.00-$-150K$0.00$0.00-$0.00
Acquisitions, net$0.00-$-93.75M$0.00$0.00$0.00
Net cash used for investing activities-$-163.46M-$-105.91M-$-54.72M$18.5M-$-19.96M
Common stock issued$0.00$195.9M$139.3M$0.00$10M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid$0.00$0.00$0.00$0.00$0.00
Net cash used for financing activities$350K$195.9M$131.7M-$-27.51M$34.8M
Net change in cash-$-176.06M$90M$77M-$-12.73M$6.8M
Cash at end of period$170K$176.2M$86.2M$9.19M$21.9M
Operating cash flow-$-12.79M$1.18M$1.35M-$-3.25M-$-8.63M
Capital expenditure-$-175.67M-$-150K$0.00$0.00-$0.00
Free cash flow-$-188.46M$1.02M$1.35M-$-3.25M-$-8.63M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Akso Health Group

        Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People’s Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

        CEO
        Yilin Wang
        Employees
        27
        Beta
        -1.00

        Explore

        Frequently asked questions

        What is the intrinsic value of Akso Health Group (AHG)?

        InvestorsCraft does not currently publish an intrinsic value for AHG. How the IC value is calculated.

        Is AHG undervalued?

        InvestorsCraft does not publish an undervaluation signal for AHG at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.